The greatest hope for answers to challenges to human health in the present and the future lies in medical innovation.
Nurturing and developing medical novelty that originates from academic research institutions or established enterprises, requires special expertise. This entails the capacity to identify market opportunities while controlling development risks, to recruit financial support, to map the critical pathway toward regulatory approval and marketing authorization, and to provide end-to-end project management, while tackling the financial challenges of that journey.
In order to master these challenges and to serve our customers even better, palleos healthcare GmbH has joined forces with the Swiss Xlife Sciences AG. Xlife sciences focusses on assisting academic inventor teams and startup companies with steering their product through the important proof-of-concept phase, toward a business case. In return, Xlife sciences offers its investors access to life science assets in very early stages of their development, while also providing the means and expertise to ensure long-term value creation.
The many years of experience of palleos makes it possible to provide customised services during the start-up phase, followed by consulting and project management during the preclinical and clinical research phase.
Through our cutting-edge project management and working with our established network of collaborators, we accelerate the journey towards overcoming public health challenges, today and tomorrow.
